gut flora metabolism phosphatidylcholine promotes cardiovascular disease
metabolomics studies hold promise discovery pathways linked disease processes cardiovascular disease cvd represents leading cause death morbidity worldwide used metabolomics approach generate unbiased small-molecule metabolic profiles plasma predict risk cvd three metabolites dietary lipid phosphatidylcholine-choline trimethylamine n-oxide tmao betaine-were identified shown predict risk cvd independent large clinical cohort dietary supplementation mice choline tmao betaine promoted upregulation multiple macrophage scavenger receptors linked atherosclerosis supplementation choline tmao promoted atherosclerosis studies using germ-free mice confirmed critical role dietary choline gut flora tmao production augmented macrophage cholesterol accumulation foam cell formation suppression intestinal microflora atherosclerosis-prone mice inhibited dietary-choline-enhanced atherosclerosis genetic variations controlling expression flavin monooxygenases enzymatic source tmao segregated atherosclerosis hyperlipidaemic mice discovery relationship gut-flora-dependent metabolism dietary phosphatidylcholine cvd pathogenesis provides opportunities development new diagnostic tests therapeutic approaches atherosclerotic heart disease
